- Home
- WAFD vs NVCR Comparison
WAFD vs NVCR Comparison
Compare WAFD & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFD
- NVCR
- Stock Information
- Founded
- WAFD 1917
- NVCR 2000
- Country
- WAFD United States
- NVCR Switzerland
- Employees
- WAFD N/A
- NVCR N/A
- Industry
- WAFD Major Banks
- NVCR Medical/Dental Instruments
- Sector
- WAFD Finance
- NVCR Health Care
- Exchange
- WAFD Nasdaq
- NVCR Nasdaq
- Market Cap
- WAFD 2.3B
- NVCR 1.9B
- IPO Year
- WAFD N/A
- NVCR 2015
- Fundamental
- Price
- WAFD $28.91
- NVCR $17.38
- Analyst Decision
- WAFD Hold
- NVCR Buy
- Analyst Count
- WAFD 5
- NVCR 6
- Target Price
- WAFD $30.60
- NVCR $32.83
- AVG Volume (30 Days)
- WAFD 535.4K
- NVCR 834.9K
- Earning Date
- WAFD 04-11-2025
- NVCR 04-24-2025
- Dividend Yield
- WAFD 3.73%
- NVCR N/A
- EPS Growth
- WAFD 1.50
- NVCR N/A
- EPS
- WAFD 2.64
- NVCR N/A
- Revenue
- WAFD $729,805,000.00
- NVCR $621,711,000.00
- Revenue This Year
- WAFD N/A
- NVCR $2.90
- Revenue Next Year
- WAFD $7.11
- NVCR $10.47
- P/E Ratio
- WAFD $10.97
- NVCR N/A
- Revenue Growth
- WAFD 12.73
- NVCR 18.27
- 52 Week Low
- WAFD $23.75
- NVCR $14.17
- 52 Week High
- WAFD $38.62
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- WAFD 56.59
- NVCR 48.17
- Support Level
- WAFD $28.37
- NVCR $16.19
- Resistance Level
- WAFD $29.31
- NVCR $17.70
- Average True Range (ATR)
- WAFD 0.70
- NVCR 0.85
- MACD
- WAFD 0.11
- NVCR 0.06
- Stochastic Oscillator
- WAFD 62.77
- NVCR 42.53
About WAFD WaFd Inc.
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.